-
High-Definition Transcranial Direct Current Stimulation-Primed Intermittent Theta Burst Stimulation in Treatment-Resistant Depression: A Controlled Study. J. ECT (IF 2.5) Pub Date : 2024-2-27 Alankrit Jaiswal, Nishant Goyal, Umesh Shreekantiah
The aim of this study was to evaluate whether high-definition transcranial direct current stimulation (HDtDCS) priming improves the efficacy of intermittent theta burst stimulation (iTBS) in improving TRD.
-
No Effect of Serum Electrolyte Levels on Electroconvulsive Therapy Seizure Quality Parameters. J. ECT (IF 2.5) Pub Date : 2024-2-27 Sebastian Karl, Alexander Sartorius, Suna Su Aksay
Seizure quality is considered to be associated with treatment outcomes of electroconvulsive therapy (ECT). A wide range of treatment parameters and patient characteristics are known to influence seizure quality. However, conflicting results exist for the role of serum electrolyte levels and seizure quality.
-
Maintenance Electroconvulsive Therapy in Catatonia: Clinical Profiles From a Case Series. J. ECT (IF 2.5) Pub Date : 2024-02-27 Joaquín Gil-Badenes, Anna Giménez-Palomo, Lucía Duque, Gabriel Pujol-Fontrodona, Erika Martínez-Amorós, Miquel Bioque
This study aims to conduct a descriptive analysis of the clinical features and treatment responses in 6 patients with catatonia who received maintenance electroconvulsive therapy (ECT).
-
Effectiveness and Safety of Flumazenil Augmentation During Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2024-02-12 Lennart Gistelinck, Nele Van de Velde, Hannelore Tandt, Pieter Verslype, Gilbert Lemmens
Benzodiazepines are considered to negatively affect seizure quality and duration during electroconvulsive therapy (ECT). Several researchers have advocated the use of flumazenil, a competitive benzodiazepine receptor antagonist, for patients treated with benzodiazepines during ECT. However, clinical evidence regarding flumazenil use in ECT remains sparse. The aim of this study is to investigate the
-
Vagus Nerve Stimulation as an Alternative to Maintenance Electroconvulsive Therapy for Difficult-to-Treat Depression. J. ECT (IF 2.5) Pub Date : 2024-02-12 Charlotte Migchels, Jasmien Obbels, Hamish McAllister-Williams, Koen Demyttenaere, Pascal Sienaert
Vagus nerve stimulation (VNS), an implantable neurostimulator, provides a valuable long-term treatment option for patients with difficult-to-treat depression. It has been reported that previous response to electroconvulsive therapy (ECT) might predict a better response to VNS and that VNS could reduce or eliminate the need for maintenance ECT in some patients. We present the case of a patient who received
-
Is the Electroconvulsive Therapy Video on YouTube Supportive Information for Patients and Their Primary Caregivers? J. ECT (IF 2.5) Pub Date : 2024-02-12 Mohammad A Abu Sabra, Mahmoud Al Kalaldeh, Mohammad R AlOsta
Electroconvulsive therapy (ECT) is a significant contemporary medical treatment modality for various mental disorders that have not responded to other treatments. YouTube is a valuable place to get health-related educational content that can have a big impact on patients' and their primary caregivers' behaviors and decisions.
-
Electroconvulsive Therapy in the United States: A 2022 Survey of Practice. J. ECT (IF 2.5) Pub Date : 2024-02-05 Rachel Noorani, Paul Rohde, Elyssa Feuer, Sarah H Lisanby, William T Regenold
This study aimed to describe current US electroconvulsive therapy (ECT) practice, identify practice changes over time, and inform discussion of practice.
-
Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations. J. ECT (IF 2.5) Pub Date : 2024-02-02 Randall T Espinoza, Zarah Antongiorgi
Glucagon-like peptide-1 receptor agonists are an emerging class of medications transforming the management of diabetes mellitus and obesity, two highly prevalent and chronic medical conditions associated with significant morbidity and posing serious public health concerns. Although generally well tolerated and relatively safe to use, case reports of patients taking these medications while undergoing
-
The Therapeutic Role of Intermittent Theta Burst Stimulation in Schizophrenia: A Systematic Review and Meta-analysis. J. ECT (IF 2.5) Pub Date : 2024-01-26 Dorsa Salabat, Amirali Pourebrahimi, Mahsa Mayeli, Giulia Cattarinussi
Schizophrenia affects approximately 1% of the population worldwide. Multifactorial reasons, ranging from drug resistance to adverse effects of medications, have necessitated exploring further therapeutic options. Intermittent theta burst stimulation (iTBS) is a novel high-frequency form of transcranial magnetic stimulation, a safe procedure with minor adverse effects with faster and longer-lasting
-
Cerebral and Aortic Aneurysms in Electroconvulsive Therapy Patients: A Systematic Review and Results From 12 Years of Screening. J. ECT (IF 2.5) Pub Date : 2024-01-25 Heiko Ullrich, Alexander Sartorius, Sebastian Karl
Theoretically, the procedural risk of electroconvulsive therapy (ECT) could be increased in the presence of undetected aneurysms due to the hemodynamic changes associated with ECT. However, empirical evidence is limited to few individual case reports and case series.
-
Perceived Barriers to Using Neurostimulation: A National Survey of Psychiatrists, Patients, Caregivers, and the General Public. J. ECT (IF 2.5) Pub Date : 2024-01-25 Marissa K Cortright, Robyn Bluhm, Eric D Achtyes, Aaron M McCright, Laura Y Cabrera
Neurostimulation interventions often face heightened barriers limiting patient access. The objective of this study is to examine different stakeholders' perceived barriers to using different neurostimulation interventions for depression.
-
Use of ECT for Children With and Without Catatonia: A Single-Site Retrospective Analysis. J. ECT (IF 2.5) Pub Date : 2024-01-25 Joshua R Smith, Isaac Baldwin, Katherine Audrey Termini, Trey McGonigle, Simon Vandekar, James Luccarelli
The objective study was to investigate the safety and efficacy of electroconvulsive therapy (ECT) in a retrospective cohort of pediatric patients.
-
Long-Term Effect of Maintenance Electroconvulsive Therapy in Patients With Depression-Data From a Small Randomized Controlled Trial. J. ECT (IF 2.5) Pub Date : 2024-01-18 Ole Brus, Yang Cao, Andreas Carlborg, Ingemar Engström, Lars von Knorring, Axel Nordenskjöld
This study aimed to compare the long-term effects of maintenance electroconvulsive therapy (M-ECT) with medication and medication only in patients with depression.
-
Oral Complications in Patients With Psychiatric Illness Undergoing Electroconvulsive Therapy in Istanbul, Turkey. J. ECT (IF 2.5) Pub Date : 2024-01-16 Ceyhan Oflezer, Özlem Oflezer, Özge Canbek, Özlem Eskil Çiçek, Hakan Bahadir
Despite advances in pharmacotherapy, electroconvulsive therapy (ECT) remains a mainstay treatment option in psychiatry. This study aims to determine the occurrence of oral injury from ECT modified with the use of an inexpensive, disposable, hand-made oral protector customized to the dental needs of the individual patient.
-
Clinical and Legal Differences in the Use of Involuntary Electroconvulsive Therapy for Life-Threatening Illness Across European Countries. J. ECT (IF 2.5) Pub Date : 2024-01-04 Mette Krarup, Charles H Kellner, Søren D Østergaard
Electroconvulsive therapy (ECT) can be life-saving in situations where patients are at risk of dying from severe manifestations of psychiatric illness. In some of these cases, patients are unwilling/unable to consent to ECT, and involuntary ECT is required. Such use of involuntary ECT varies substantially across European countries for unclear reasons. The aim of this study was to examine clinical and
-
Structural Changes in Depressed Patients Directly After Treatment With Electroconvulsive Therapy and 3 Months Later. J. ECT (IF 2.5) Pub Date : 2023-12-29 Stevie Jaarsveld, Peter Mulders, Indira Tendolkar, Philip van Eijndhoven
It is assumed that neuroplasticity plays a central role in the effect of electroconvulsive therapy (ECT) on patients with major depressive disorder. We carried out an explorative study to map out the extent in which gray matter volume changes could be found directly after ECT treatment and after follow-up.
-
Catatonia in Preadolescent Children. J. ECT (IF 2.5) Pub Date : 2023-12-29 Lara De Stefano, Alexander Palffy, Neera Ghaziuddin
The aim of the study is to describe prepubescent catatonia in very young children, which is poorly documented in the current literature and, as a result, overlooked in medical settings.
-
Electroconvulsive Therapy Across Nations: A 2022 Survey of Practice. J. ECT (IF 2.5) Pub Date : 2023-12-08 Paul Rohde, Rachel Noorani, Elyssa Feuer, Sarah H Lisanby, William T Regenold
We aimed to characterize worldwide electroconvulsive therapy (ECT) practice and compare practice across nations and global regions.
-
Ketamine as an Alternative Anesthetic for Augmenting Seizure Durations During Electroconvulsive Therapy: A Retrospective Observational Study. J. ECT (IF 2.5) Pub Date : 2023-12-08 Sarara Mutoh, Michiko Kinoshita, Yuki Maeda, Katsuya Tanaka
Electroconvulsive therapy (ECT) is highly effective for severe psychiatric disorders; however, short seizure durations may lead to ineffective therapy. This retrospective study aimed to examine the risks and benefits of switching to ketamine anesthesia to augment seizure durations during an acute course of ECT.
-
Decarbonizing the International Society for ECT and Neurostimulation. J. ECT (IF 2.5) Pub Date : 2023-12-01 C Edward Coffey
-
Comments on "Postanesthesia Recovery Unit Optimization for Patients With Postictal Agitation Secondary to Electroconvulsive Therapy" by Arora et al. J. ECT (IF 2.5) Pub Date : 2023-12-01 Christian M Beilstein,Agnes Meyer,Lutz E Lehmann,Patrick Y Wuethrich
-
Editor's Roundup for Issue #4 of 2023: What Patients and Their Families Are Reading About Electroconvulsive Therapy (ECT) on the Internet; Enhancing Self-efficacy Regarding Managing Cognitive Side Effects of ECT; Rank Order of Change in Depressive Symptoms After ECT; and (Still More) About Ketamine and ECT. J. ECT (IF 2.5) Pub Date : 2023-12-01 William V McCall
-
Open AI Chat, Anti-Electroconvulsive Therapy Statements and References: Comment. J. ECT (IF 2.5) Pub Date : 2023-12-01 Amnuay Kleebayoon,Rujittika Mungmunpuntipantip,Viroj Wiwanitkit
-
Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode: A Register-Based Study. J. ECT (IF 2.5) Pub Date : 2023-11-30 Pontus Strandberg, Axel Nordenskjöld, Robert Bodén, Carl Johan Ekman, Johan Lundberg, Katarzyna Popiolek
Electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) are both effective in treating depression. Although rTMS induces fewer adverse effects, its effectiveness relative to ECT is not well established. The aim of this study was to investigate the treatment outcomes of ECT and rTMS in patients who have received both interventions.
-
Augmenting Virtual Reality Exposure Therapy for Social and Intergroup Anxiety With Transcranial Direct Current Stimulation. J. ECT (IF 2.5) Pub Date : 2023-11-27 Mollie A McDonald, Samantha J Meckes, Jorja Shires, Marian E Berryhill, Cynthia L Lancaster
Exposure therapy is a cornerstone of social anxiety treatment, yet not all patients respond. Symptoms in certain social situations, including intergroup (ie, out-group) contexts, may be particularly resistant to treatment. Exposure therapy outcomes may be improved by stimulating neural areas associated with safety learning, such as the medial prefrontal cortex (mPFC). The mPFC also plays an important
-
Distinguishing Convulsive Syncope From Seizure Induced by Repetitive Transcranial Magnetic Stimulation: A Case Report. J. ECT (IF 2.5) Pub Date : 2023-11-27 Fahad Mukhtar, Elyssa Feuer, Lysianne Beynel, Eudora Jones, William T Regenold, Sarah H Lisanby
Repetitive transcranial magnetic stimulation (rTMS) is Food and Drug Administration cleared for clinical use in treatment-resistant depression and a growing list of other disorders. The clinical uptake of rTMS has been facilitated by its relatively benign adverse-effect profile compared with other treatment modalities. Seizure is a rare but serious adverse event that has been reported with rTMS, when
-
Psychometric Properties of the Chinese Version of the ElectroConvulsive Therapy Cognitive Assessment: An Electroconvulsive Therapy-Specific Cognitive Screening Tool. J. ECT (IF 2.5) Pub Date : 2023-11-27 Xinyu Liu, Sixiang Liang, Jun Liu, Sha Sha, Ling Zhang, Wei Jiang, Changqing Jiang, Adriana P Hermida, Yilang Tang, William M McDonald, Yanping Ren, Gang Wang
Electroconvulsive therapy (ECT) is an effective somatic treatment, but it may be limited by cognitive adverse effects. The existing cognitive screening instruments often lack specificity to ECT-associated cognitive deficits. The ElectroConvulsive Therapy Cognitive Assessment was developed and validated in a clinical setting, but the reliability and validity of the Chinese version of ElectroConvulsive
-
A Multicenter Retrospective Chart Review on the Effectiveness and Tolerability of Electroconvulsive Therapy in Adolescents and Young Adults With Major Depressive Disorder or Bipolar Depression. J. ECT (IF 2.5) Pub Date : 2023-11-16 Nout Schukking, Karel W F Scheepstra, Isidoor O Bergfeld, Jeroen A van Waarde, Indira Tendolkar, Harm-Pieter Spaans, Annette J M Hegeman, Dominique S Scheepens, Anja Lok
Major depressive disorder and bipolar depression in adolescents and young adults are prevalent and major contributors to the global burden of disease, whereas effective interventions are limited. Available evidence is insufficient to assess effectiveness and tolerability of electroconvulsive therapy in depressed adolescents and young adults.
-
Todd Paralysis After Electroconvulsive Therapy-Letter to the Editor. J. ECT (IF 2.5) Pub Date : 2023-10-30 Travis Josephs,Emilia Ballou,Zulfi Haneef,Ali Abbas Asghar-Ali
-
Editor's Roundup for Issue 3 of 2023: Modeling Intracerebral Temperature and Voltages During Electroconvulsive Therapy, Relief of Suicidal Ideation in Adolescents With Electroconvulsive Therapy, the Risk of Suicide Death With Loss of Access to Electroconvulsive Therapy During COVID-19, and Management of Takotsubo Cardiomyopathy in Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2023-09-01 William V McCall
-
Large Language Models and Psychoeducation: Correspondence. J. ECT (IF 2.5) Pub Date : 2023-08-03 Amnuay Kleebayoon,Viroj Wiwanitkit
-
Intermittent Theta Burst Stimulation Using H7 Coil for Management of Negative Symptoms and Cognitive Dysfunction in Chronic Schizophrenia: A Case Report. J. ECT (IF 2.5) Pub Date : 2023-08-03 Manul Das,Anchal Saxena,Subham Samantaray,Sujeet Kumar,Justin Raj Pc,Nishant Goyal
-
Electroconvulsive therapy Credentialing for Psychiatrists-Review of Required Standards Across States and Territories in Australia. J. ECT (IF 2.5) Pub Date : 2023-08-03 Subramanian Purushothaman,Brett Simpson,Salam Hussain,Colleen K Loo,Shane Gill,Suneel Chamoli,Alan Weiss,Shanthi Sarma,Paul B Fitzgerald,Matthew Fasnacht,Ashu Gandhi
Electroconvulsive therapy (ECT) is a complex medical procedure, the delivery of which requires specialist knowledge and skills. We reviewed the standards required for ECT credentialing in different jurisdictions in Australia. We reviewed the Chief Psychiatrist guidelines and statewide policy standards on ECT and focused on standards required for initial credentialing and ongoing privileging in ECT
-
Development of Complete Heart Block During ECT Requiring Emergent Implantation of a Permanent Pacemaker. J. ECT (IF 2.5) Pub Date : 2023-08-03 Anthony Purgianto
-
Electroconvulsive Therapy in Heart Transplant Patients: To Avoid or Embrace? J. ECT (IF 2.5) Pub Date : 2023-08-03 Evan Ketcham,Oliver M Glass,Adriana P Hermida
Patients with heart disease are at an increased risk of depression. Electroconvulsive therapy (ECT) is a highly effective treatment for severe depressive episodes. However, ECT may increase the risk for adverse outcomes in certain patients because of changes in blood pressure and heart rate secondary to an initial parasympathetic surge followed by a sympathetic surge and peripheral catecholamine release
-
Reflections: Psychological Risks With Borderline Personality Disorder in Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2023-07-20 William V McCall,Amy House,Peter B Rosenquist
-
Receipt of Electroconvulsive Therapy in Outpatient Settings in a National Sample of Privately Insured Patients With Mood Disorders. J. ECT (IF 2.5) Pub Date : 2023-07-20 Edeanya Agbese, Douglas L Leslie, Robert Rosenheck
Electroconvulsive therapy (ECT), an effective treatment for bipolar and major depressive disorder, is underused. Little information is available on use of ECT in potentially less costly outpatient settings, possibly reducing cost barriers.
-
A Retrospective Matched Comparison Study of Prolonged Seizures in ECT. J. ECT (IF 2.5) Pub Date : 2023-07-20 Keith Isenberg, Stephen H Dinwiddie, Jing Song, Carol S North
This study assessed the incidence of and risk factors for prolonged seizures (>180 sec) in electroconvulsive therapy (ECT).
-
Personality Difficulties as a Predictor of Electroconvulsive Therapy Response in Depression. J. ECT (IF 2.5) Pub Date : 2023-07-04 Martha Finnegan,Toni Galligan,Ana Jelovac,Declan M McLoughlin
-
An Adolescent Girl With Systematic Lupus Erythematosus Presenting With Treatment Suprarefractory Catatonia: Moderating Role of Steroid and the Response to ECT. J. ECT (IF 2.5) Pub Date : 2023-07-04 Sujita Kumar Kar,Puneet Kumar,Kopal Rohatgi,Suyash Dwivedi
-
Intermittent Theta-Burst Stimulation for Memory Modulation in a Patient With Mild Cognitive Impairment and Trigeminal Neuralgia. J. ECT (IF 2.5) Pub Date : 2023-07-04 Margaret L McAllister,Matthew A Slayton,Noreen Bukhari-Parlakturk,Andy J Liu,Angel V Peterchev,Simon W Davis
-
Open AI Chat Fabricated Anti-Electroconvulsive Therapy Statements and References. J. ECT (IF 2.5) Pub Date : 2023-06-26 Conrad M Swartz
-
The Role of the Autonomic Nervous System in the Mediation of the Resolution of Suicidal Ideation With Electroconvulsive Therapy: A Hypothesis and Review of Heart Rate Variability Over a Course of Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2023-06-26 William V McCall, Alvin Thomas, Brian J Miller, Peter B Rosenquist
Longitudinal observational studies have shown a meaningful decrease in suicidal thinking and suicidal behavior after receipt of electroconvulsive therapy (ECT). The antisuicide effect of ECT may be related to success in the global relief of the presenting syndrome such as depressive or psychotic illness. However, it is possible that the antisuicide effect is specific to ECT per se, over and above the
-
A Pilot Study of Adjunctive Group Therapy to Enhance Coping With Cognitive Challenges and Support Cognitive Health After Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2023-06-26 Marc L Copersino, Nicole R DeTore, Cynthia Piltch, Paula Bolton, Teresa Henderson, Vona F Davis, Elizabeth S Eberlin, Lynn Kadden, Susan R McGurk, Stephen J Seiner, Kim T Mueser
Concerns about the cognitive adverse effects of electroconvulsive therapy (ECT) are common among recipients of the treatment despite its relatively small adverse effects on cognitive functioning. Interventions aimed at remediating or improving coping with cognitive adverse effects of ECT have not been developed. The Enhancing Cognitive Domains after ECT (ENCODE) program is a new group intervention
-
ChatGPT on ECT: Can Large Language Models Support Psychoeducation? J. ECT (IF 2.5) Pub Date : 2023-06-12 Robert M Lundin,Michael Berk,Søren Dinesen Østergaard
-
Aphasia Following Electroconvulsive Therapy: A Case Report With a Literature Review of Published Cases. J. ECT (IF 2.5) Pub Date : 2023-06-05 Sarah Kassir,Francky Teddy Endomba,Chanèse Amghar,Clément Guillet
-
Safety of Repetitive Transcranial Magnetic Stimulation in Patients With Cardiac Pacemakers: A Case Report. J. ECT (IF 2.5) Pub Date : 2023-05-31 Ashok Jammigumpula,Jithin T Joseph,Vidyashree Manibettu,Abhiram N Purohith,Sonia Shenoy,Suma Udupa,Samir Kumar Praharaj
-
Subanesthetic Dose of Ketamine Administered Before Each Electroconvulsive Therapy Session Improves Antidepressant and Sleep Quality Outcomes: A Randomized, Controlled Trial. J. ECT (IF 2.5) Pub Date : 2023-05-31 Jun Dong, Su Min, Qibing Chen, HaiTang Qiu, Li Ren
The main purpose of this trial is to explore the effects of subanesthetic dose of ketamine on sleep quality and symptoms in patients with major depressive disorder undergoing bitemporal electroconvulsive therapy (ECT).
-
Electroconvulsive Therapy in Patients With Cerebral Aneurysms. J. ECT (IF 2.5) Pub Date : 2023-05-26 Christopher Shane Buntting, David Tran, Charles Fish, Gurkirat Chatha, Rondhir Jithoo
Subarachnoid hemorrhage due to cerebral aneurysm rupture is a devastating event with a high mortality and significant morbidity. The safety of patients undergoing electroconvulsive therapy (ECT) in the presence of an aneurysm is not clear and is a cause of anxiety for both health care workers and patients. The present article collated the available evidence related to ECT in the presence of an aneurysm
-
Accelerated Transcranial Magnetic Stimulation Provided Rapid Improvement in Depressive, Anxiety, Trauma, and Pain Symptoms in a Woman Experiencing Postpartum Depression. J. ECT (IF 2.5) Pub Date : 2023-05-18 Megan Senda,Kevin Johnson,Isabelle Taylor,Mariah Jensen,Heather Flynn,F Andrew Kozel
-
Unintended Weight Gain After Treatment of Catatonia With ECT in Autism: Case Report and Literature Review. J. ECT (IF 2.5) Pub Date : 2023-05-18 Melissa Free, Aum Pathare, Yassir Mahgoub
Catatonia is a syndrome with psychomotor, cognitive, and affective symptoms that has been associated with multiple psychiatric and medical conditions, including autism spectrum disorder. Fluctuations in weight can occur within catatonia by means of poor oral intake, treatment with atypical antipsychotics, and often overlooked psychomotor phenomena. We present a case of a patient with autism spectrum
-
Accelerated Intermittent Theta-Burst Stimulation for Treatment of Therapy-Resistant Depression in a Patient With Epilepsy and Implanted Vagus Nerve Stimulator: A Case Report. J. ECT (IF 2.5) Pub Date : 2023-06-19 Mohamed A Abdelnaim,Martin Schecklmann,Verena Lang-Hambauer,Tobias Hebel,Franziska Weber,Berthold Langguth
-
Dynamics of Depressive and Psychomotor Symptoms During Electroconvulsive Therapy in Older Depressive Patients: A Case Series. J. ECT (IF 2.5) Pub Date : 2023-05-12 Erwan Le Droguene, Samuel Bulteau, Thibault Deschamps, Véronique Thomas-Ollivier, Clara Brichant-Petitjean, Marie Guitteny, Andrew Laurin, Anne Sauvaget
Electroconvulsive therapy (ECT) is an effective treatment for patients experiencing a major depressive episode, especially older ones. Identification of specific responses within early ECT sessions remains an issue of debate, however. Hence, this pilot study prospectively examined the outcome in terms of depressive signs, symptom by symptom, throughout a course of ECT, concentrating particularly on
-
What Our Patients and Their Families Are Reading: Quality and Readability of Internet Information About Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2023-05-12 Okan Ekinci
The Internet is now more widely used than before by psychiatric patients and their families to search for medical conditions and treatments. To our knowledge, no study has addressed the quality and readability of online information about electroconvulsive therapy (ECT). We aimed to examine the quality and readability of English-language Internet information related to ECT.
-
Exploring New Electroencephalogram Parameters in Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2023-05-12 Jakob Emil Schreiner, Ute Kessler, Ketil Joachim Oedegaard, Kent-Andre Mardal, Leif Oltedal
This pilot study aims to evaluate a novel metric based on the power spectrum of the EEG recordings from ECT-induced seizures-its association to volume changes in the hippocampus after ECT and improvement in depression rating scores.
-
Editor's Roundup for Issue 2 of 2023: The Critical Role of Anesthesia Management in the Success of Electroconvulsive Therapy. J. ECT (IF 2.5) Pub Date : 2023-05-09 William V McCall
-
Long-Term Management of Schizophrenia With Maintenance rTMS: A Case Report. J. ECT (IF 2.5) Pub Date : 2023-04-24 Nicole Sargent,Rebecca M Allen
-
Automatic Change in Pacemaker Mode During Electroconvulsive Therapy in a Patient With an Implantable Cardiac Pacemaker. J. ECT (IF 2.5) Pub Date : 2023-04-24 Yuji Kadoi,Masato Sano,Tatsuhito Nakano,Shigeru Saito
-
Neuropsychology of Depression, Edited by Shawn M. McClintock and Jimmy Choi, The Guilford Press, 2022. J. ECT (IF 2.5) Pub Date : 2023-04-24 Charles H Kellner
-
Theta-Burst Stimulation 3 Times a Day for Treatment-Resistant Depression-A New Protocol: Case Series. J. ECT (IF 2.5) Pub Date : 2023-04-24 Matheus Rassi Fernandes Ramos,Valquíria Aparecida da Silva,Beatriz Araújo Cavendish,Juliana Pereira de Sousa,Alessandra Santos Fonseca,Matthias Stephan Luthi,André Russowsky Brunoni